Literature DB >> 9365697

A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation.

J Norrby1, M Olausson.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9365697     DOI： 10.1016/s0041-1345(97)00813-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Post-transplant lymphoproliferative disease: association with induction therapy?

Authors:  Vikas R Dharnidharka
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study.

Authors:  F Burkhalter; S Schaub; Ch Bucher; L Gürke; A Bachmann; H Hopfer; M Dickenmann; J Steiger; I Binet
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

3.  Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Turun Song; Saifu Yin; Xingxing Li; Yamei Jiang; Tao Lin
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.